Andrew Meadows signed Scribe Therapeutics Inc.'s 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Scribe Therapeutics Inc.'s EIN is 82-2157847.
Download the official 2024 Form 5500 (PDF) for Scribe Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Scribe Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).